List of Excipients in API DAROLUTAMIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing DAROLUTAMIDE
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Bayer HealthCare Pharmaceuticals Inc | NUBEQA | darolutamide | 50419-395 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | 2038-02-27 |
Bayer HealthCare Pharmaceuticals Inc | NUBEQA | darolutamide | 50419-395 | CROSCARMELLOSE SODIUM | 2038-02-27 |
Bayer HealthCare Pharmaceuticals Inc | NUBEQA | darolutamide | 50419-395 | LACTOSE MONOHYDRATE | 2038-02-27 |
Bayer HealthCare Pharmaceuticals Inc | NUBEQA | darolutamide | 50419-395 | MAGNESIUM STEARATE | 2038-02-27 |
Bayer HealthCare Pharmaceuticals Inc | NUBEQA | darolutamide | 50419-395 | POLYETHYLENE GLYCOL 3350 | 2038-02-27 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for DAROLUTAMIDE
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
DAROLUTAMIDE drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
Bayer HealthCare Pharmaceuticals Inc | darolutamide | 50419-395 |
>Company | >Ingredient | >NDC |
DAROLUTAMIDE drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
DAROLUTAMIDE drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Bayer HealthCare Pharmaceuticals Inc | darolutamide | 50419-395 |
>Company | >Ingredient | >NDC |
DAROLUTAMIDE drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
DAROLUTAMIDE drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Bayer HealthCare Pharmaceuticals Inc | darolutamide | 50419-395 |
>Company | >Ingredient | >NDC |
DAROLUTAMIDE drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
DAROLUTAMIDE drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Bayer HealthCare Pharmaceuticals Inc | darolutamide | 50419-395 |
>Company | >Ingredient | >NDC |
DAROLUTAMIDE drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
DAROLUTAMIDE drug variants containing POLYETHYLENE GLYCOL 3350
Company | Ingredient | NDC |
---|---|---|
Bayer HealthCare Pharmaceuticals Inc | darolutamide | 50419-395 |
>Company | >Ingredient | >NDC |
DAROLUTAMIDE drug variants not containing POLYETHYLENE GLYCOL 3350
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
DAROLUTAMIDE drug variants containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Bayer HealthCare Pharmaceuticals Inc | darolutamide | 50419-395 |
>Company | >Ingredient | >NDC |
DAROLUTAMIDE drug variants not containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
DAROLUTAMIDE drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Bayer HealthCare Pharmaceuticals Inc | darolutamide | 50419-395 |
>Company | >Ingredient | >NDC |
DAROLUTAMIDE drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.